| |
| |
|
| Insider
Information: |
Klein Joseph III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
86,717 |
|
|
Indirect Shares
|
111 |
|
|
| Direct
Value |
$3,758,117 |
|
|
|
Indirect Value
|
$3,784 |
|
|
| Total
Shares |
86,828 |
|
|
| Total
Value |
$3,761,901 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-3.0
|
| Percentage
Gain/Loss : |
 127.5%
|
 -83.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
as of May 22, 2007 |
2007-05-23 |
0 |
2003-09-11 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2010-03-08 |
35,000 |
2007-03-07 |
0 |
Premium* |
|
|
Clinical Data Inc |
CLDA |
Former Director |
2006-10-11 |
1,000 |
|
0 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2024-05-03 |
16,346 |
2024-05-03 |
100 |
Premium* |
|
|
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2010-06-08 |
17,388 |
2006-06-01 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2009-11-04 |
16,983 |
2009-11-04 |
11 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-11-10 |
4 |
B |
$17.00 |
$169,980 |
D/D |
10,000 |
13,100 |
2.39 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2005-03-11 |
4 |
B |
$11.05 |
$110,512 |
D/D |
10,000 |
38,100 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2008-03-03 |
4 |
S |
$38.00 |
$380,333 |
D/D |
(10,000) |
30,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2008-08-11 |
4 |
S |
$18.55 |
$185,799 |
D/D |
(10,000) |
8,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-02-24 |
4 |
B |
$12.08 |
$120,784 |
D/D |
10,000 |
32,500 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2010-03-08 |
4 |
S |
$22.12 |
$221,227 |
D/D |
(10,000) |
35,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2015-03-05 |
4 |
OE |
$9.22 |
$101,800 |
D/D |
10,000 |
11,095 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2014-01-24 |
4 |
OE |
$12.94 |
$158,800 |
D/D |
10,313 |
5,126 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2014-01-24 |
4 |
S |
$48.61 |
$501,838 |
D/D |
(10,313) |
2,313 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-03-19 |
4 |
AS |
$18.00 |
$201,222 |
I/I |
(11,179) |
0 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-03-19 |
4 |
OE |
$5.93 |
$66,291 |
I/I |
11,179 |
3,727 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2007-03-07 |
4 |
S |
$16.36 |
$196,397 |
I/I |
(12,000) |
0 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2005-03-10 |
4 |
B |
$11.27 |
$171,012 |
D/D |
15,000 |
28,100 |
2.39 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-08-09 |
4 |
S |
$28.22 |
$529,126 |
D/D |
(18,750) |
8,313 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-08-09 |
4 |
OE |
$9.22 |
$190,950 |
D/D |
18,750 |
15,813 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2006-08-09 |
4 |
S |
$15.52 |
$310,320 |
D/D |
(20,000) |
10,000 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-06-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
28,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2008-03-03 |
4/A |
S |
$37.80 |
$758,333 |
D/D |
(20,000) |
20,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-03-13 |
4 |
OE |
$5.17 |
$108,144 |
I/I |
20,800 |
6,667 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-03-13 |
4 |
AS |
$18.01 |
$374,544 |
I/I |
(20,800) |
0 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-11-04 |
4 |
S |
$8.29 |
$199,815 |
D/D |
(24,000) |
16,983 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-11-04 |
4 |
OE |
$6.89 |
$165,456 |
D/D |
24,000 |
40,983 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2006-08-09 |
4 |
OE |
$7.72 |
$231,600 |
D/D |
30,000 |
30,000 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2008-02-29 |
4 |
OE |
$14.21 |
$426,300 |
D/D |
30,000 |
40,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2008-02-29 |
4/A |
OE |
$14.21 |
$426,300 |
D/D |
30,000 |
40,000 |
0 |
- |
|
178 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
